These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Not reported||2012-001609-25||A RandomizEd, Double-masked, Placebo-controlled Study of the SafetY and Efficacy of GevokizUmAb in the TReatment of Subjects with Non-infectious IntermeDiate, Posterior, or Pan- uveitis Currently Cont...||2015-11-11||due-trials|
|Not reported||2012-001610-42||A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis||2015-11-11||due-trials|
|Ongoing, reported early||2015-002847-32||A Single-Dose Open-Label Study of XOMA 358 in Subjects with Congenital Hyperinsulinism (HI)||not-yet-due|
|Completed, but no date||2015-005751-27||A Multi-Center, Open-Label, Randomized, Single-Dose, Controlled Trial of Intravenously Administered XOMA 213 in Suppression of Lactation after Delivery in Postpartum Women||bad-data|
|Reported results||2016-001275-80||An Open-Label Study of XOMA 358, with Optional Dose Escalation, in Patients with Congenital Hyperinsulinism||2017-01-20||due-trials|
|Ongoing||2016-004186-83||An Open-Label Multiple-Dose Study of XOMA 358 in Patients with Congenital Hyperinsulinism||not-yet-due|